RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications

  1. Garcia-Gomez, A.
  2. Ocio, E.M.
  3. Pandiella, A.
  4. San Miguel, J.F.
  5. Garayoa, M.
Aldizkaria:
Investigational New Drugs

ISSN: 0167-6997,  1573-0646

Argitalpen urtea: 2013

Alea: 31

Zenbakia: 1

Orrialdeak: 200-205

Mota: Artikulua

DOI: 10.1007/S10637-012-9845-3 GOOGLE SCHOLAR